Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer-Reference-Cited by-同舟云学术

Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer

Published:2021-06 Issue:5 Volume:12 Page:813-819
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Johns Andrew C.,Wei Lai,Grogan Madison,Hoyd Rebecca,Bridges John F.P.,Patel Sandipkumar H.,Li Mingjia,Husain Marium,Kendra Kari L.,Otterson Gregory A.,Burkart Jarred T.,Rosko Ashley E.,Andersen Barbara L.,Carbone David P.,Owen Dwight H.,Spakowicz Daniel J.,Presley Carolyn J.

Funder

National Cancer Institute

National Institute on Aging

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference30 articles.

1. Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials;O’Connor;JAMA Oncol,2018

3. Primary, adaptive, and acquired resistance to cancer immunotherapy;Sharma;Cell.,2017

5. FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: a 10-year experience by the US Food and Drug Administration;Singh,2017

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity profile of camrelizumab-based immunotherapy in older adults with advanced cancer;Scientific Reports;2024-08-16

2. Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study;Cancer Letters;2024-08

3. PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review;International Immunopharmacology;2024-03

4. Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma;Drugs & Aging;2024-03

5. Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors;Current Oncology;2023-10-19